X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (22) 22
oncology (18) 18
humans (17) 17
female (10) 10
middle aged (10) 10
adult (9) 9
aged (9) 9
male (9) 9
hematology, oncology and palliative medicine (8) 8
treatment outcome (7) 7
aged, 80 and over (6) 6
cancer (6) 6
lung neoplasms - drug therapy (6) 6
survival (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
chemotherapy (5) 5
disease progression (5) 5
lung cancer (5) 5
lung neoplasms - genetics (5) 5
open-label (5) 5
carcinoma, non-small-cell lung - drug therapy (4) 4
carcinoma, non-small-cell lung - genetics (4) 4
clinical trials (4) 4
erlotinib (4) 4
immunotherapy (4) 4
lung neoplasms - mortality (4) 4
lung neoplasms - therapy (4) 4
non-small cell lung cancer (4) 4
phase-iii (4) 4
prognosis (4) 4
protein kinase inhibitors - therapeutic use (4) 4
pulmonary/respiratory (4) 4
respiratory system (4) 4
retrospective studies (4) 4
targeted therapy (4) 4
time factors (4) 4
breast cancer (3) 3
carcinoma, non-small-cell lung - mortality (3) 3
carcinoma, non-small-cell lung - therapy (3) 3
care and treatment (3) 3
checkpoint inhibitors (3) 3
disease-free survival (3) 3
double-blind (3) 3
egfr mutation (3) 3
gefitinib (3) 3
lung cancer, non-small cell (3) 3
lung cancer, small cell (3) 3
lung neoplasms - pathology (3) 3
medical research (3) 3
metastasis (3) 3
multivariate analysis (3) 3
neoplasm staging (3) 3
patient selection (3) 3
patients (3) 3
predictive value of tests (3) 3
protein kinase inhibitors - adverse effects (3) 3
research design (3) 3
review (3) 3
risk factors (3) 3
survival analysis (3) 3
tyrosine kinase inhibitors (3) 3
young adult (3) 3
1st-line gefitinib (2) 2
acquired resistance (2) 2
adenocarcinoma (2) 2
adjuvant chemotherapy (2) 2
afatinib (2) 2
albumin (2) 2
analysis (2) 2
antibody-drug conjugate (2) 2
antineoplastic agents (2) 2
antineoplastic agents - therapeutic use (2) 2
article (2) 2
atezolizumab (2) 2
aurora kinase (2) 2
biology (2) 2
biomarkers (2) 2
brain metastases (2) 2
cell lung-cancer (2) 2
cell-lung-cancer (2) 2
docetaxel (2) 2
egfr tyrosine kinase inhibitors (2) 2
erbb receptors - genetics (2) 2
feasibility studies (2) 2
first line (2) 2
guidelines (2) 2
hematology (2) 2
immune therapy (2) 2
immunotherapy - methods (2) 2
kaplan-meier estimate (2) 2
malignant pleural mesothelioma (2) 2
medicine, experimental (2) 2
metastatic melanoma (2) 2
mutation (2) 2
mutations (2) 2
non small cell lung cancer (2) 2
nsclc (2) 2
overall survival prediction (2) 2
personalized peptide vaccination (2) 2
placebo-controlled trial (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Sullivan, Patrick and Yuan, Maoli and Coleman, John and Destefano, Joanne and Zhang, Xinsheng and Yates, Nicole and Barouch, Dan and Ackerman, Margaret and Decamp, Allan and Alter, Galit and Tomaras, Georgia and Tomaras, Georgia and Montefiori, David and Montefiori, David and Rasmussen, Beth and Morrow, Gavin and Koff, Wayne and Kashuba, Angela and Kashuba, Angela and Mascola, John and Picker, Louis and Kent, Stephen and Selhorst, Philippe and Masson, Lindi and Ngandu, Nobubelo and Rademeyer, Cecilia and Karim, Quarraisha Abdool and Kijak, Gustavo and Barouch, Dan and Rasheed, Ata Ur and Havenar-Daughton, Colin and Pham, Matthew and Kovalenkov, Yevgeniy and Gumber, Sanjeev and Johnson, Matthew and Wrammert, Jens and Villinger, Francois and Haynes, Barton and Haynes, Barton and Fox, Christopher and Reed, Steve and Vasilakos, John and Tomai, Mark and Crotty, Shane and Ahmed, Rafi and Pulendran, Bali and Fukazawa, Yoshinori and Lifson, Jeffrey and Lifson, Jeffrey and Moore, Penny and Chatora, Kumbirai and Skorochod, Elisabeth and Madidi, Ngonidzashe and Gomez, Anabel and Ncube, Getrude and Sundaram, Maaya and Kretschmer, Steve and Pauthner, Matthias and Briney, Bryan and Lee, Jeong Hyun and Saye-Francisco, Karen and Hsueh, Jessica and Ramos, Alejandra and Le, Khoa and Jones, Meaghan and Jardine, Joseph and Bastidas, Raiza and Sarkar, Anita and Liang, Chi-Hui and Wilson, Ian and Ward, Andrew and Zhu, Jiang and Poignard, Pascal and Burton, Dennis and Krebs, Shelly and Law, Wiliam and Gift, Syna and Chenine, Agnes and Rolland, Morgane and Moody, M. Anthony and Jarosinski, Marissa and Georgiev, Ivelin and Chuang, Gwo-Yu and Chuang, Gwo-Yu and Asokan, Mangaiarkarasi and Bailer, Robert T and Cale, Evan M and Louder, Mark and Kwong, Peter D and Polonis, Victoria and Tovanabutra, Sodsai and Robb, Merlin and Mascola, John R and Wibmer, Constantinos Kurt and Wibmer, Constantinos Kurt and Madzorera, Vimbai S and Doria-Rose, Nicole A and Morris, Lynn and Moore, Penny L and Anthony, Colin and ...
AIDS Research and Human Retroviruses, ISSN 0889-2229, 10/2016, Volume 32, Issue S1, pp. 1 - 409
Journal Article
European Respiratory Review, ISSN 0905-9180, 2014, Volume 23, Issue 133, pp. 367 - 378
In the genomics era, our main goal should be to identify large and meaningful differences in small, molecularly selected groups of patients. Classical phase I,... 
Diagnostic Imaging | Immunotherapy - methods | Thoracic Neoplasms - drug therapy | Research Design | Humans
Journal Article
Cell Reports, ISSN 2211-1247, 08/2016, Volume 16, Issue 9, pp. 2327 - 2338
Journal Article
AIDS Research and Human Retroviruses, ISSN 0889-2229, 10/2018, Volume 34, Issue S1, pp. 1 - 407
Journal Article
British Journal of Cancer, ISSN 0007-0920, 10/2018, Volume 119, Issue 8, pp. 937 - 939
BACKGROUND: Reliable evaluation of treatment benefit in early phase clinical trials is necessary. The time to progression ratio (TTPr), which compares... 
END-POINTS | TARGETS | ONCOLOGY | TUMORS | Brief Communication
Journal Article
The Lancet Respiratory Medicine, ISSN 2213-2600, 10/2019, Volume 7, Issue 10, pp. 835 - 837
Journal Article
Nuclear Medicine Communications, ISSN 0143-3636, 08/2019, Volume 40, Issue 8, pp. 802 - 807
AIMThe aim of this study was to assess the predictive role of fluorine-18-fluorodeoxyglucose (F-FDG) PET/computed tomography (CT) in the evaluation of response... 
Journal Article
International Journal of Technology Assessment in Health Care, ISSN 0266-4623, 2018, Volume 34, Issue 1, pp. 3 - 9
Journal Article
Expert Review of Anticancer Therapy, ISSN 1473-7140, 02/2019, Volume 19, Issue 2, pp. 151 - 167
Introduction: Small cell lung cancer (SCLC) is a tumor with a poor prognosis, often diagnosed in an advanced stage. Despite aggressive treatment of early and... 
Checkpoint inhibitors | targeted therapy | immune therapy | small cell lung cancer | vaccination therapy | ANTIBODY-DRUG CONJUGATE | CELL-LUNG-CANCER | POTENTIAL THERAPEUTIC TARGET | OPEN-LABEL | AURORA KINASE | ONCOLOGY | RANDOMIZED PHASE-II | REGULATORY T-CELLS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | PERSONALIZED PEPTIDE VACCINATION
Journal Article
Journal Article
Expert Review of Clinical Pharmacology, ISSN 1751-2433, 09/2019, Volume 12, Issue 9, pp. 831 - 840
Introduction: Different EGFR tyrosine kinase inhibitors (TKIs) are currently approved for the first-line treatment of NSCLC patients with EGFR mutations.... 
non-small cell lung cancer | tyrosine kinase inhibitors | Dacomitinib | EGFR mutations | irreversible inhibitor
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e14025 - e14025
Journal Article
European Journal of Cancer, ISSN 0959-8049, 10/2017, Volume 84, pp. 212 - 218
Journal Article